Healthcare provider profile · identity verified

Kimberly J Herder, MD

Internal Medicine · PORTLAND, OR · NPI 1811975741

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	556	155
Levothyroxine Sodium	Levothyroxine Sodium	302	85
Lisinopril	Lisinopril	239	65
Metoprolol Succinate	Metoprolol Succinate	178	55
Amlodipine Besylate	Amlodipine Besylate	177	54
Omeprazole	Omeprazole	151	45
Trazodone Hcl	Trazodone Hcl	139	35
Oxycodone Hcl	Oxycodone Hcl	136	20
Eliquis	Apixaban	128	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	128	42
Losartan Potassium	Losartan Potassium	124	39
Gabapentin	Gabapentin	101	29
Pantoprazole Sodium	Pantoprazole Sodium	100	31
Irbesartan	Irbesartan	97	31
Rosuvastatin Calcium	Rosuvastatin Calcium	92	27
Hydrochlorothiazide	Hydrochlorothiazide	90	31
Sertraline Hcl	Sertraline Hcl	90	28
Metformin Hcl	Metformin Hcl	79	25
Alendronate Sodium	Alendronate Sodium	78	24
Escitalopram Oxalate	Escitalopram Oxalate	78	23
Lorazepam	Lorazepam	72	15
Buspirone Hcl	Buspirone Hcl	70	18
Albuterol Sulfate Hfa	Albuterol Sulfate	65	31
Citalopram Hbr	Citalopram Hydrobromide	65	17
Famotidine	Famotidine	61	13
Potassium Chloride	Potassium Chloride	57	20
Duloxetine Hcl	Duloxetine Hcl	56	14
Donepezil Hcl	Donepezil Hcl	55	12
Furosemide	Furosemide	55	22
Metoprolol Tartrate	Metoprolol Tartrate	55	14
Zolpidem Tartrate	Zolpidem Tartrate	51	17
Bupropion Xl	Bupropion Hcl	50	14
Ondansetron Odt	Ondansetron	50	15
Metformin Hcl Er	Metformin Hcl	47	16
Simvastatin	Simvastatin	47	13
Glipizide Er	Glipizide	46	13
Glipizide	Glipizide	45	12
Spironolactone	Spironolactone	43	14
Ozempic	Semaglutide	41	suppressed
Tramadol Hcl	Tramadol Hcl	41	16
Warfarin Sodium	Warfarin Sodium	39	14
Pravastatin Sodium	Pravastatin Sodium	38	13
Tamsulosin Hcl	Tamsulosin Hcl	38	11
Fluoxetine Hcl	Fluoxetine Hcl	37	11
Atenolol	Atenolol	36	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Estradiol	Estradiol	31	14
Fluticasone Propionate	Fluticasone Propionate	31	18
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Alprazolam	Alprazolam	30	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	11
Clopidogrel	Clopidogrel Bisulfate	28	11
Allopurinol	Allopurinol	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Meloxicam	Meloxicam	24	11
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Diazepam	Diazepam	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	12
Carvedilol	Carvedilol	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Ondansetron Hcl	Ondansetron Hcl/Pf	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Baclofen	Baclofen	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Trulicity	Dulaglutide	17	suppressed
Jardiance	Empagliflozin	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Torsemide	Torsemide	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Prednisone	Prednisone	13	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Estradiol (Once Weekly)	Estradiol	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Premarin	Estrogens, Conjugated	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Belsomra	Suvorexant	11	suppressed
Cephalexin	Cephalexin	11	11
Fentanyl	Fentanyl	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed
Nucynta Er	Tapentadol Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error